Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.8 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.7 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.41NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.90 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.23NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.30NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.1.1.12NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.87NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.33NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.46NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.58 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.26NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.15NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.21NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.31NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CP.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBGNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.98 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.32NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.1.1.13NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
EF.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XPNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
DN.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BE.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.1.1.15NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.3.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CQ.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
EC.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.52NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FS.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.5.54NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.29NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.29NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
N.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
P.1.15 (Gamma)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.348NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.575NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
C.26NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Q.4 (Alpha)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.442NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
P.1.1 (Gamma)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
A.2.5.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.600NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
P.1.12 (Gamma)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.525 (Eta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.6 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.5.5 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
P.1.7 (Gamma)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.24 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.45 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used